# Dianthus Therapeutics, Inc.: Form SC 13D/A, filed Dec 3, 2024

- Company: [Dianthus Therapeutics, Inc.](/companies/dnth.md) (CIK 1690585)
- Form: SC 13D/A
- Filed: 2024-12-03
- Accepted by EDGAR: Dec 3, 2024, 21:19 ET
- Period: not reported
- Accession: 0000919574-24-006998
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1690585/000091957424006998/d11540500_13d-a.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1690585/000091957424006998/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1690585/000091957424006998/d11540500_13d-a.htm

Filed Dec 3, 2024.
Source: SEC EDGAR, the filing index for accession 0000919574-24-006998. Last ingested by Listed: Nov 4, 2026, 16:45 ET. No prices; not investment advice.